Narrow Therapeutic Window of Ribavirin as an Inhibitor of Nitric Oxide Synthesis is Broadened by Macromolecular Prodrugs
Ribavirin (RBV), a broad-spectrum antiviral agent, is a standard medication against hepatitis C virus (HCV). However, despite the decades of clinical success, the mechanism of action of this drug against HCV remains a subject of debate. Furthermore, the appeal of this therapeutic agent is considerab...
Saved in:
Published in | Biomacromolecules Vol. 14; no. 11; pp. 3916 - 3926 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Chemical Society
11.11.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!